WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across Asia, Europe, and North America, we offer integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform. We are privileged to work alongside nearly 6,000 partners across 30+ countries, supporting their efforts to bring breakthrough treatments to patients. Guided by our vision that every drug can be made and every disease can be treated, we are committed to advancing breakthroughs for patients—one collaboration at a time. Learn more at www.wuxiapptec.com
Shared 2 weeks ago
7 views
Shared 2 weeks ago
3 views
Shared 2 weeks ago
11 views
Shared 2 weeks ago
3 views
Shared 2 months ago
90 views
Shared 6 months ago
96 views
Shared 6 months ago
168 views
Shared 6 months ago
108 views
Shared 6 months ago
83 views
Shared 6 months ago
56 views
Shared 6 months ago
31 views
Shared 7 months ago
101 views
Shared 7 months ago
47 views
Shared 7 months ago
103 views
Shared 7 months ago
222 views
Shared 7 months ago
56 views
Shared 7 months ago
47 views
A Global Village for Global Impact: Talk with Michael Altorfer, CEO of the Swiss Biotech Association
Shared 8 months ago
57 views
Shared 8 months ago
51 views
Shared 3 years ago
33 views
Shared 3 years ago
110 views
Shared 3 years ago
46 views
Shared 3 years ago
54 views
Shared 3 years ago
13 views
Shared 3 years ago
34 views
Shared 3 years ago
12 views
Fragile X Syndrome: Innovative Approaches to Finding a Cure |Targeted Therapy (Christopher Missling)
Shared 3 years ago
192 views
Shared 3 years ago
10 views
Shared 3 years ago
53 views
Fragile X Syndrome: Innovative Approaches to Finding a Cure |Targeted Therapy Adrian Newman-Tancredi
Shared 3 years ago
12 views
Shared 3 years ago
41 views
Shared 3 years ago
44 views
Shared 3 years ago
25 views
Shared 3 years ago
8 views
Shared 3 years ago
13 views
Shared 3 years ago
12 views
Shared 3 years ago
8 views
Shared 3 years ago
34 views
Shared 3 years ago
59 views
Shared 3 years ago
6 views
Shared 3 years ago
21 views
Shared 3 years ago
5 views
Shared 3 years ago
6 views
Shared 3 years ago
14 views